Hyderabad: The efficacy and safety levels of the vaccine developed by Russia for treating COVID-19 patients is not predictable in the absence of data, a
Hyderabad: The efficacy and safety levels of the vaccine developed by Russia for treating COVID-19 patients is not predictable in the absence of data, a top official of theCSIR-Centre for Cellular and Molecular Biology said on Wednesday. His remarks come in the backdrop of Russian President Vladimir Putin’s announcement that his country has developed the world’s first vaccine against coronavirus. Director of CCMB, Rakesh K Mishra said if people are “lucky” then the Russian vaccine will work. “Both, efficacy and safety of the vaccine is still unknown. They haven’t conducted proper trials, whichis stage-III trials. That is when you get to know the efficacy, when it is tested on a large number of people and wait for two months and see whether they get a viral infection or not.
